MétaCan
Menu
← Back to cohort
Record W4416084970 · doi:10.1093/neuonc/noaf201.0591

CTP-19. Molecular characterization of the SJMB12 clinical trial for children and young adults with newly diagnosed medulloblastoma

2025· article· en· W4416084970 on OpenAlexaff
Kyle Smith, Sandeep Kumar Dhanda, Doug Strother, Michael J. Fisher, Anne Bendel, Eugene Hwang, Sibo Zhao, Nicholas G. Gottardo, Tim Hassall, Jennifer Elster, Sébastien Perreault, Vijay Ramaswamy, Sonia Partap, Stephen Laughton, Richard J. Cohn, Murali Chintagumpala, Geoffrey McCowage, Michael Sullivan, Elias Sayour, Daniel C. Bowers, Asher Marks, Avery Wright, Arzu Onar‐Thomas, Amar Gajjar, Giles Robinson, Paul A. Northcott

Bibliographic record

VenueNeuro-Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicGlioma Diagnosis and Treatment
Canadian institutionsHospital for Sick ChildrenCentre Hospitalier Universitaire Sainte-JustineAlberta Children's Hospital
Fundersnot available
KeywordsGermlinePTCH1MedulloblastomaGermline mutationExome sequencingExonGeneClinical trialExome

Abstract

fetched live from OpenAlex

Abstract The SJMB12 (NCT01878617) clinical trial introduced a molecular subgroup-based approach to the treatment of newly diagnosed medulloblastoma by stratifying 649 evaluable patients into WNT, SHH, and non-WNT/non-SHH strata. While the genomic landscape of medulloblastoma has been extensively characterized, most prior studies analyzed heterogenous or non-trial-associated cohorts, which may not capture the true distribution of oncogenic drivers within a clinically homogeneous population. To address this limitation, we used 1) Illumina EPIC DNA methylation array for subgroup/subtype classification and detection of copy number alterations; 2) whole exome sequencing for detection of single-/multi-nucleotide variants and small insertions/deletions; 3) RNA sequencing for detection of gene overexpression and fusions. In the WNT-stratum (n=90), 96% of profiled tumors harbored canonical exon 3 hotspot mutations in CTNNB1, while the remaining 4% exhibited inactivation of APC, consistent with aberrant WNT/β-catenin pathway activation. Additionally, we identified mutually exclusive loss-of-function mutations affecting several genes on chromosome 6 - LATS1 (8%), FOXO3 (8%), and CSNK2B (9%), co-occurring exclusively with monosomy 6. In the SHH-stratum (n=107), 51% of tumors exhibited PTCH1 inactivation, which was the most prevalent gene-level alteration. Germline loss-of-function variants in ELP1 or TP53 were observed in ~30% of cases, highlighting the clinical utility of germline testing. Three patients exhibited hypermutator phenotypes, with tumor mutational burdens 100x higher than the cohort median. These individuals carried pathogenic germline variants in mismatch repair genes MSH6 or PMS2, consistent with Lynch/Turcot type I syndromes. Notably, two of the three patients also harbored somatic POLE mutations, likely contributing to replication error–driven mutagenesis. In the nonWNT/nonSHH stratum (n=452), beyond known drivers, we identified a novel mechanism of GFI1B enhancer hijacking resulting from an interchromosomal translocation, as opposed to proximal structural variants. The molecular results presented here will be further integrated with survival outcomes and used to inform the design of future clinical trials.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.013

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.311
Teacher spread0.298 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-Oncology→Same topicGlioma Diagnosis and Treatment→French-language works237,207→